Hims & Hers is up 10.1%, or $1.89 to $20.58. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on HIMS: Hims & Hers price target raised to $23 from $20 at BofA Truist sees FDA review of Tirzepatide shortage as positive for Him & Hers Hims & Hers rises 7.2% Hims & Hers rises 8.3% FDA to reconsider barring compounded versions of weight loss drug, Reuters says Disclaimer & DisclosureReport an Issue
